Alan Martin Mathiowetz

Person

Quaker Hill, CT, US

People

Patents Grantslast 30 patents

Information Patent Grant
GLP-1 receptor agonists and uses thereof
- Patent number 11,858,916
- Issue date Jan 2, 2024
- Pfizer Inc.
- Gary Erik Aspnes
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
GLP-1 receptor agonists and uses thereof
- Patent number 11,802,121
- Issue date Oct 31, 2023
- Pfizer Inc.
- Gary Erik Aspnes
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
GLP-1 receptor agonists and uses thereof
- Patent number 11,512,070
- Issue date Nov 29, 2022
- Pfizer Inc.
- Gary Erik Aspnes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
GLP-1 receptor agonists and uses thereof
- Patent number 10,934,279
- Issue date Mar 2, 2021
- Pfizer Inc.
- Gary Erik Aspnes
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
GLP-1 receptor agonists and uses thereof
- Patent number 10,851,081
- Issue date Dec 1, 2020
- Pfizer Inc.
- Gary Erik Aspnes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
GLP-1 receptor agonists and uses thereof
- Patent number 10,683,281
- Issue date Jun 16, 2020
- Pfizer Inc.
- Gary Erik Aspnes
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
GLP-1 receptor agonists and uses thereof
- Patent number 10,676,465
- Issue date Jun 9, 2020
- Pfizer Inc.
- Gary Erik Aspnes
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
GLP-1 receptor agonists and uses thereof
- Patent number 10,669,259
- Issue date Jun 2, 2020
- Pfizer Inc.
- Gary Erik Aspnes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
GLP-1 receptor agonists and uses thereof
- Patent number 10,208,019
- Issue date Feb 19, 2019
- Pfizer Inc.
- Gary Erik Aspnes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antagonists of prostaglandin EP3 receptor
- Patent number 9,278,953
- Issue date Mar 8, 2016
- Pfizer Inc.
- Kevin Barry Bahnck
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
SMALL MOLECULE COMPOUNDS
- Publication number 20240350463
- Publication date Oct 24, 2024
- APERTOR PHARMACEUTICALS, INC.
- Edmund Graziani
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
SUBSTITUTED INDAZOLE PROPIONIC ACID DERIVATIVE COMPOUNDS AND USES T...
- Publication number 20240336572
- Publication date Oct 10, 2024
- Pfizer Inc.
- Samit Kumar Bhattacharya
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GLP-1 Receptor Agonists and Uses Thereof
- Publication number 20240132483
- Publication date Apr 25, 2024
- Pfizer Inc.
- Gary Erik Aspnes
- C07 - ORGANIC CHEMISTRY
Information Patent Application
GLP-1 Receptor Agonists and Uses Thereof
- Publication number 20240059679
- Publication date Feb 22, 2024
- Pfizer Inc.
- Gary Erik Aspnes
- C07 - ORGANIC CHEMISTRY
Information Patent Application
GLP-1 RECEPTOR AGONISTS AND USES THEREOF
- Publication number 20240034725
- Publication date Feb 1, 2024
- Pfizer Inc.
- Gary Erik Aspnes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GLP-1 RECEPTOR AGONISTS AND USES THEREOF
- Publication number 20230124938
- Publication date Apr 20, 2023
- Pfizer Inc.
- Gary Erik Aspnes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SMALL MOLECULE COMPOUNDS
- Publication number 20230104503
- Publication date Apr 6, 2023
- The Regents of the University of California
- Edmund GRAZIANI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Solid Forms of 2-((4-((S)-2-(5-Chloropyridin-2-yl)-2-methylbenzo[d]...
- Publication number 20230045419
- Publication date Feb 9, 2023
- Pfizer Inc.
- Gary E. Aspnes
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINATIONS COMPRISING BENZODIOXOL AS GLP-1R AGONISTS FOR USE IN T...
- Publication number 20220387402
- Publication date Dec 8, 2022
- Pfizer Inc.
- Gary E. Aspnes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GLP-1 Receptor Agonists and Uses Thereof
- Publication number 20210332034
- Publication date Oct 28, 2021
- Pfizer Inc.
- Gary Erik Aspnes
- C07 - ORGANIC CHEMISTRY
Information Patent Application
GLP-1 Receptor Agonists and Uses Thereof
- Publication number 20210163455
- Publication date Jun 3, 2021
- Pfizer Inc.
- Gary Erik Aspnes
- C07 - ORGANIC CHEMISTRY
Information Patent Application
GLP-1 RECEPTOR AGONISTS AND USES THEREOF
- Publication number 20210047298
- Publication date Feb 18, 2021
- Pfizer Inc.
- Gary Erik Aspnes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GLP-1 RECEPTOR AGONISTS AND USES THEREOF
- Publication number 20200255406
- Publication date Aug 13, 2020
- Pfizer Inc.
- Gary Erik Aspnes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GLP-1 Receptor Agonists and Uses Thereof
- Publication number 20190382387
- Publication date Dec 19, 2019
- Pfizer Inc.
- Gary Erik Aspnes
- C07 - ORGANIC CHEMISTRY
Information Patent Application
GLP-1 Receptor Agonists and Uses Thereof
- Publication number 20190382384
- Publication date Dec 19, 2019
- Pfizer Inc.
- Gary Erik Aspnes
- C07 - ORGANIC CHEMISTRY
Information Patent Application
GLP-1 Receptor Agonists and Uses Thereof
- Publication number 20190382388
- Publication date Dec 19, 2019
- Pfizer Inc.
- Gary Erik Aspnes
- C07 - ORGANIC CHEMISTRY
Information Patent Application
GLP-1 Receptor Agonists and Uses Thereof
- Publication number 20190119255
- Publication date Apr 25, 2019
- Pfizer Inc.
- Gary Erik Aspnes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GLP-1 Agonists and Uses Thereof
- Publication number 20180170908
- Publication date Jun 21, 2018
- Pfizer Inc.
- Gary Erik Aspnes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTAGONISTS OF PROSTAGLANDIN EP3 RECEPTOR
- Publication number 20150099782
- Publication date Apr 9, 2015
- Pfizer Inc.
- Kevin Barry Bahnck
- C07 - ORGANIC CHEMISTRY

Alan Martin Mathiowetz

Person

Patents Grantslast 30 patents

GLP-1 receptor agonists and uses thereof

GLP-1 receptor agonists and uses thereof

GLP-1 receptor agonists and uses thereof

GLP-1 receptor agonists and uses thereof

GLP-1 receptor agonists and uses thereof

GLP-1 receptor agonists and uses thereof

GLP-1 receptor agonists and uses thereof

GLP-1 receptor agonists and uses thereof

GLP-1 receptor agonists and uses thereof

Antagonists of prostaglandin EP3 receptor

Patents Applicationslast 30 patents

SMALL MOLECULE COMPOUNDS

SUBSTITUTED INDAZOLE PROPIONIC ACID DERIVATIVE COMPOUNDS AND USES T...

GLP-1 Receptor Agonists and Uses Thereof

GLP-1 Receptor Agonists and Uses Thereof

GLP-1 RECEPTOR AGONISTS AND USES THEREOF

GLP-1 RECEPTOR AGONISTS AND USES THEREOF

SMALL MOLECULE COMPOUNDS

Solid Forms of 2-((4-((S)-2-(5-Chloropyridin-2-yl)-2-methylbenzo[d]...

COMBINATIONS COMPRISING BENZODIOXOL AS GLP-1R AGONISTS FOR USE IN T...

GLP-1 Receptor Agonists and Uses Thereof

GLP-1 Receptor Agonists and Uses Thereof

GLP-1 RECEPTOR AGONISTS AND USES THEREOF

GLP-1 RECEPTOR AGONISTS AND USES THEREOF

GLP-1 Receptor Agonists and Uses Thereof

GLP-1 Receptor Agonists and Uses Thereof

GLP-1 Receptor Agonists and Uses Thereof

GLP-1 Receptor Agonists and Uses Thereof

GLP-1 Agonists and Uses Thereof

ANTAGONISTS OF PROSTAGLANDIN EP3 RECEPTOR